Robert W. Postma - 22 Jun 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Reporting owner
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Issuer context
Transaction snapshot
SEC evidence
Form type
4
Filing time
24 Jun 2022, 16:35:17 UTC
Previous filing
03 Sep 2021
Next filing
01 Dec 2022
SEC filing
View on sec.gov

Key filing fact

Robert W. Postma filed Form 4 for Alaunos Therapeutics, Inc. (TCRT) on 24 Jun 2022.

Key facts

  • This page summarizes Robert W. Postma's Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 24 Jun 2022, 16:35.

Change

  • Previous filing in this sequence was filed on 03 Sep 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

TCRT transaction

Common Stock

Award

Transaction value
$0
Shares
+40,000
Change %
+3.3%
Price
$0.000000
Shares after
1,241,870
Date
22 Jun 2022
Ownership
Direct
Footnotes
F1
TCRT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,250,000
Date
22 Jun 2022
Ownership
See Footnote
Footnotes
F2
TCRT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,574
Date
22 Jun 2022
Ownership
By Spouse's IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

TCRT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+100,000
Change %
Price
$0.000000
Shares after
100,000
Date
22 Jun 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
100,000
Exercise price
$0.8200
Footnotes
F3
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer.
F2 The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
F3 The option vests in twelve equal monthly installments beginning on July 13, 2022.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .